Skip to main content
Equibles

Legal & General Group Plc

Position in FTRE — Fortrea Holdings Inc.

CIK 764068 London, X0
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,901,270
+$1,911,099 QoQ
Shares Held
224,211
+6.1% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 334 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. FTRE ranks #54 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in FTRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,901,270 224,211
2026-03-31 $1,990,171 211,271
2025-12-31 $3,838,607 222,528
2025-09-30 $1,326,242 157,511
2025-06-30 $1,192,198 241,336
2025-03-31 $1,786,351 236,603
2024-12-31 $4,514,716 242,076
2024-09-30 $4,869,240 243,462
2024-06-30 $5,969,087 255,745
2023-12-31 $10,424,175 298,687
2023-09-30 $13,972,904 488,734